Main Article Content


Chronic obstructive pulmonary disease is a complex disease with heterogeneous presentation, progression, and structural abnormality that is currently graded solely on clinical and physiologic parameters. Thoracic computed tomography imaging holds promise for phenotyping in chronic obstructive pulmonary disease, but despite increasing availability, this methodology has yet to be incorporated into clinical guidelines or routine clinical practice. However, the unique clinical implications of emphysema and airways disease are becoming clearer. Emphysema has a strong association with more rapid disease progression and mortality. Airways disease has a strong relationship with symptoms and health status. It is hoped that future refinement of emphysema assessment allowing for quantitative subtyping will also increase our ability to define clinically meaningful subgroups, as will development of methodologies to assess airways disease and, in particular, small airways through inspiratory/expiratory image registration techniques. Most important, however, is the need for longitudinal data, in not only observational but also therapeutic settings, such that the impact of interventions on radiographically defined phenotypes can be assessed.   


Chronic obstructive tomography imaging

Article Details

How to Cite
Althalmi , D. S. A. A. (2023). Characteristics Feature of Chronic Obstructive Pulmonary Disease Correlation with Clinical Finding. Central Asian Journal of Medical and Natural Science, 4(3), 257-262.


  1. 1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. 2014. [Last accessed on 2015 Apr 11]. Available from:
  2. 2. Chugh T, Goel N, Bhargava SK, Kumar R. Correlation of physiological and radiological characteristics in COPD. Indian J Chest Dis Allied Sci. 2012;54:235–42.
  3. 3. Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Transl Res. 2013;162(4):208–218.
  4. 4. Gershon AS, Wang C, Wilton AS, Raut R, To T. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med. 2010;170(6):560–565.
  5. 5. Bischoff EW, Schermer TR, Bor H, Brown P, van Weel C, van den Bosch WJ. Trends in COPD prevalence and exacerbation rates in Dutch primary care. Br J Gen Pract. 2009;59(569):927–933.
  6. 6. Schirnhofer L, Lamprecht B, Vollmer WM, et al. COPD prevalence in salzburg, austria: results from the burden of obstructive lung disease (BOLD) study. Chest. 2007;131(1):29–36.
  7. 7. Akinbami LJ, Liu X. Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 19982009. NCHS Data Brief. 2011;(63):1–8.
  8. 8. WHO. WHO report on the global tobacco epidemic. 2019. Available from: Accessed September 05, 2020.
  9. 9. Sansores RH, Ramirez-Venegas A. COPD in women: susceptibility or vulnerability? Eur Respir J. 2016;47(1):19–22.
  10. 1. 10.1183/ 13993003.01781-2015 10. Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med. 2004;10 (2):98–103.
  11. 10. Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122. doi:10.1186/1465-9921-11-122
  12. 11. Dransfield MT, Washko GR, Foreman MG, Estepar RS, Reilly J, Bailey WC. Gender differences in the severity of CT emphysema in COPD. Chest. 2007;132(2):464–470.
  13. 12. Ni Y, Shi G, Yu Y, Hao J, Chen T, Song H. Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2015;10:1465–1475.
  14. 13. Naberan K, Azpeitia A, Cantoni J, Miravitlles M. Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir Med. 2012;106(3):367–373.
  15. 14. Jia G, Lu M, Wu R, Chen Y, Yao W. Gender difference on the knowledge, attitude, and practice of COPD diagnosis and treatment: a national, multicenter, cross-sectional survey in China. Int J Chron Obstruct Pulmon Dis. 2018;13:3269–3280.
  16. 15. Myong JP, Yoon HK, Rhee CK, Kim HR, Koo JW. Risk factors for lung function impairment among the general non-smoking Korean population. Int J Tuberc Lung Dis. 2015;19(9):1019–1026,
  17. 16. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366(9500):1875–1881.
  18. 17. Bhome AB. COPD in India: iceberg or volcano? J Thorac Dis. 2012;4(3):298–309.
  19. 18. Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753–760.
  20. 19. Korea Centers for Disease Control. Korea national health & nutrition examination survey. Available from: knhanes/eng/ Accessed September 05, 2020.
  21. 20. Lou P, Zhu Y, Chen P, et al. Vulnerability of patients with chronic obstructive pulmonary disease according to gender in China. Int J Chron Obstruct Pulmon Dis. 2012;7:825–832.